{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:15:20Z","timestamp":1792592120418,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1065854"],"award-info":[{"award-number":["1065854"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2000732"],"award-info":[{"award-number":["2000732"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021727","name":"Berlin University Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021727","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.placenta.2025.11.013","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:39:22Z","timestamp":1764261562000},"page":"19-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Thrombospondin-1 (THBS1) is dysregulated in preeclampsia"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1183-5631","authenticated-orcid":false,"given":"Stefan M.","family":"Botha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy A.","family":"Bartho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunhild","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuong-Vi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Dechend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Nonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu'uhevaha J.","family":"Kaitu'u-Lino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2025.11.013_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103780","article-title":"Clinical tools and biomarkers to predict preeclampsia","volume":"75","author":"MacDonald","year":"2022","journal-title":"EBioMedicine"},{"issue":"10297","key":"10.1016\/j.placenta.2025.11.013_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","article-title":"Pre-eclampsia","volume":"398","author":"Chappell","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.placenta.2025.11.013_bib3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.placenta.2025.11.013_bib4","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: variations on the theme","volume":"30","author":"Roberts","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2025.11.013_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","article-title":"The two-stage placental model of preeclampsia: an update","volume":"134\u2013135","author":"Staff","year":"2019","journal-title":"J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.placenta.2025.11.013_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0143-4004(91)90339-H","article-title":"Current topic: pre-eclampsia and the placenta","volume":"12","author":"Redman","year":"1991","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2025.11.013_bib7","article-title":"Pre-eclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.placenta.2025.11.013_bib8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/hr.2010.92","article-title":"Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia","volume":"33","author":"Molvarec","year":"2010","journal-title":"Hypertens. Res."},{"issue":"7","key":"10.1016\/j.placenta.2025.11.013_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2S","key":"10.1016\/j.placenta.2025.11.013_bib10","doi-asserted-by":"crossref","first-page":"S1019","DOI":"10.1016\/j.ajog.2020.10.022","article-title":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders","volume":"226","author":"Rana","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2025.11.013_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.preghy.2018.03.010","article-title":"Prospective biomarkers in preterm preeclampsia: a review","volume":"14","author":"McCarthy","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.placenta.2025.11.013_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejogrb.2021.01.039","article-title":"Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: a systematic review and meta-analysis","volume":"258","author":"Margioula-Siarkou","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.placenta.2025.11.013_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.preghy.2021.11.006","article-title":"Circulating activin A is elevated at 36 weeks' gestation preceding a diagnosis of preeclampsia","volume":"27","author":"Wong","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.placenta.2025.11.013_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105870","article-title":"The association between circulating SIGLEC6 and preeclampsia: observational studies of seven cohorts","volume":"118","author":"Kaitu'u-Lino","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.placenta.2025.11.013_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.placenta.2019.04.005","article-title":"The association between first trimester AFP to PAPP-A ratio and placentally-related adverse pregnancy outcome","volume":"81","author":"Hughes","year":"2019","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib17","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1038\/s41467-021-24215-4","article-title":"Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy","volume":"12","author":"Vanhoutte","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.placenta.2025.11.013_bib18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ijcard.2013.04.139","article-title":"The role of thrombospondin-1 in cardiovascular health and pathology","volume":"168","author":"Krishna","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.placenta.2025.11.013_bib19","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jvs.2009.11.073","article-title":"Thrombospondin-1: a proatherosclerotic protein augmented by hyperglycemia","volume":"51","author":"Maier","year":"2010","journal-title":"J. Vasc. Surg."},{"issue":"10","key":"10.1016\/j.placenta.2025.11.013_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047451","article-title":"Sustained beta-cell dysfunction but normalized islet mass in aged thrombospondin-1 deficient mice","volume":"7","author":"Drott","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2025.11.013_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1479-5876-9-10","article-title":"Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning","volume":"9","author":"Efimenko","year":"2011","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib22","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1038\/s41467-023-41095-y","article-title":"THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer","volume":"14","author":"Omatsu","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.placenta.2025.11.013_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10147-024-02472-9","article-title":"Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer","volume":"29","author":"Li","year":"2024","journal-title":"Int. J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.placenta.2025.11.013_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/jop.12430","article-title":"THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma","volume":"45","author":"Pal","year":"2016","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.placenta.2025.11.013_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.matbio.2023.03.011","article-title":"Controlled extracellular proteolysis of thrombospondins","volume":"119","author":"Carminati","year":"2023","journal-title":"Matrix Biol."},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/71517","article-title":"Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1","volume":"6","author":"Jimenez","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.placenta.2025.11.013_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/296069","article-title":"Thrombospondin-1: multiple paths to inflammation","volume":"2011","author":"Lopez-Dee","year":"2011","journal-title":"Mediat. Inflamm."},{"issue":"10","key":"10.1016\/j.placenta.2025.11.013_bib28","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2174\/138945008785909365","article-title":"Regulation of thrombospondin1 by extracellular proteases","volume":"9","author":"Iruela-Arispe","year":"2008","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/mrd.23710","article-title":"A pilot study on the relationship between thrombospondin-1 (THBS1) and transforming growth factor beta1 (TGFbeta1) in the bovine placenta during early mid-pregnancy as well as parturition with normally released and retained placenta","volume":"91","author":"Wawrzykowski","year":"2024","journal-title":"Mol. Reprod. Dev."},{"issue":"5","key":"10.1016\/j.placenta.2025.11.013_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006627","article-title":"Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2","volume":"2","author":"Lawler","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.placenta.2025.11.013_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.638536","article-title":"Thrombospondin 1 in metabolic diseases","volume":"12","author":"Gutierrez","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.placenta.2025.11.013_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.niox.2019.11.006","article-title":"Nitric oxide signaling in pregnancy and preeclampsia","volume":"95","author":"Sutton","year":"2020","journal-title":"Nitric Oxide"},{"issue":"3","key":"10.1016\/j.placenta.2025.11.013_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.gendis.2020.05.007","article-title":"THBS1 regulates trophoblast fusion through a CD36-dependent inhibition of cAMP, and its upregulation participates in preeclampsia","volume":"8","author":"Duan","year":"2021","journal-title":"Genes Dis."},{"issue":"21","key":"10.1016\/j.placenta.2025.11.013_bib34","article-title":"Thrombospondin-1 regulates trophoblast necroptosis via NEDD4-Mediated ubiquitination of TAK1 in preeclampsia","volume":"11","author":"Hu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"15","key":"10.1016\/j.placenta.2025.11.013_bib35","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1080\/14767058.2018.1441279","article-title":"Maternal serum thrombospondin-1 is significantly altered in cases with established preeclampsia","volume":"32","author":"Ulu","year":"2019","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"6","key":"10.1016\/j.placenta.2025.11.013_bib36","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2025.11.013_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.placenta.2023.07.013","article-title":"Cell surface associated protein mucin 15 (MUC15) is elevated in preeclampsia","volume":"140","author":"Nguyen","year":"2023","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib38","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/s41467-020-16346-x","article-title":"Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction","volume":"11","author":"Kaitu'u-Lino","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.stem.2017.11.004","article-title":"Derivation of human trophoblast stem cells","volume":"22","author":"Okae","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.placenta.2025.11.013_bib40","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.placenta.2014.06.374","article-title":"Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells","volume":"35","author":"Brownfoot","year":"2014","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.placenta.2025.11.013_bib41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.preghy.2014.09.003","article-title":"Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin","volume":"4","author":"Kaitu'u-Lino","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.placenta.2025.11.013_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.placenta.2024.08.018","article-title":"Leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) is reduced with preeclampsia and small for gestational aged fetuses","volume":"156","author":"Bartho","year":"2024","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-96823-9","article-title":"Cystatin 6 (CST6) and legumain (LGMN) are potential mediators in the pathogenesis of preeclampsia","volume":"15","author":"Botha","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib44","doi-asserted-by":"crossref","DOI":"10.1242\/dev.199840","article-title":"Cell trajectory modeling identifies a primitive trophoblast state defined by BCAM enrichment","volume":"149","author":"Shannon","year":"2022","journal-title":"Development"},{"key":"10.1016\/j.placenta.2025.11.013_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/s12015-024-10764-w","article-title":"Trophoblast side-population markers are dysregulated in preeclampsia and fetal growth restriction","author":"Wong","year":"2024","journal-title":"Stem. Cell Rev. Rep."},{"issue":"7955","key":"10.1016\/j.placenta.2025.11.013_bib46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-023-05869-0","article-title":"Spatial multiomics map of trophoblast development in early pregnancy","volume":"616","author":"Arutyunyan","year":"2023","journal-title":"Nature"},{"issue":"6771","key":"10.1016\/j.placenta.2025.11.013_bib47","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/35001608","article-title":"Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis","volume":"403","author":"Mi","year":"2000","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.placenta.2025.11.013_bib48","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1096\/fasebj.6.6.1544544","article-title":"HLA and maternal-fetal recognition","volume":"6","author":"Hunt","year":"1992","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.placenta.2025.11.013_bib49","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.placenta.2015.05.017","article-title":"ERBB2 gene amplification increases during the transition of proximal EGFR(+) to distal HLA-G(+) first trimester cell column trophoblasts","volume":"36","author":"Meinhardt","year":"2015","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.placenta.2025.11.013_bib50","doi-asserted-by":"crossref","DOI":"10.1242\/dev.148932","article-title":"PLAC8, a new marker for human interstitial extravillous trophoblast cells, promotes their invasion and migration","volume":"145","author":"Chang","year":"2018","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.placenta.2025.11.013_bib51","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cyto.2015.07.021","article-title":"The adipokine preadipocyte factor-1 is downregulated in preeclampsia and expressed in placenta","volume":"75","author":"Schrey","year":"2015","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.placenta.2025.11.013_bib52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.stemcr.2016.01.006","article-title":"What is trophoblast? A combination of criteria define human first-trimester trophoblast","volume":"6","author":"Lee","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.placenta.2025.11.013_bib53","series-title":"Pathology of the Human Placenta","first-page":"871","author":"Benirschke","year":"1995"},{"issue":"8","key":"10.1016\/j.placenta.2025.11.013_bib54","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41576-023-00586-w","article-title":"Best practices for single-cell analysis across modalities","volume":"24","author":"Heumos","year":"2023","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.placenta.2025.11.013_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/molehr\/gaac014","article-title":"The roles of ADAMDEC1 in trophoblast differentiation during normal pregnancy and preeclampsia","volume":"28","author":"Li","year":"2022","journal-title":"Mol. Hum. Reprod."},{"issue":"Pt B","key":"10.1016\/j.placenta.2025.11.013_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semcdb.2023.05.008","article-title":"Emerging functions of thrombospondin-1 in immunity","volume":"155","author":"Kaur","year":"2024","journal-title":"Semin. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.placenta.2025.11.013_bib57","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/CS20150702","article-title":"The role of inflammation in the pathology of preeclampsia","volume":"130","author":"Harmon","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"issue":"6","key":"10.1016\/j.placenta.2025.11.013_bib58","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.semnephrol.2004.07.008","article-title":"The renal response to preeclampsia","volume":"24","author":"Moran","year":"2004","journal-title":"Semin. Nephrol."},{"issue":"6","key":"10.1016\/j.placenta.2025.11.013_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/CLD.0000000000000088","article-title":"Hypertensive complications of pregnancy: hepatic consequences of preeclampsia through HELLP syndrome","volume":"22","author":"Mei","year":"2023","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-024-03318-x","article-title":"Thrombospondin 1 enhances systemic inflammation and disease severity in acute-on-chronic liver failure","volume":"22","author":"Hassan","year":"2024","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.placenta.2025.11.013_bib61","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1523-1755.2004.00395.x","article-title":"Thrombospondin-1 is a major activator of TGF-Beta in fibrotic renal disease in the rat in vivo","volume":"65","author":"Daniel","year":"2004","journal-title":"Kidney Int."},{"issue":"29","key":"10.1016\/j.placenta.2025.11.013_bib62","article-title":"Single-cell spatial transcriptomics unveils platelet-fueled cycling macrophages for kidney fibrosis","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"5","key":"10.1016\/j.placenta.2025.11.013_bib63","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood.2020005382","article-title":"Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets","volume":"137","author":"Aburima","year":"2021","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.placenta.2025.11.013_bib64","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1182\/blood-2010-01-265561","article-title":"Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP\/protein kinase A signaling Cascade","volume":"116","author":"Roberts","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.placenta.2025.11.013_bib65","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1182\/blood-2007-06-098392","article-title":"Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide\/cGMP signaling","volume":"111","author":"Isenberg","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.placenta.2025.11.013_bib66","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/cvr\/cvq218","article-title":"Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation","volume":"88","author":"Bauer","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.placenta.2025.11.013_bib67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/CIRCRESAHA.117.305262","article-title":"Thrombospondin-1 (TSP1) contributes to the development of vascular inflammation by regulating monocytic cell motility in mouse models of abdominal aortic aneurysm","volume":"117","author":"Liu","year":"2015","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib68","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12933-024-02315-x","article-title":"Data-independent LC-MS\/MS analysis of ME\/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery","volume":"23","author":"Nunes","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.placenta.2025.11.013_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102633","article-title":"Enhanced thrombospondin-1 causes dysfunction of vascular endothelial cells derived from fabry disease-induced pluripotent stem cells","volume":"52","author":"Do","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/cvr\/cvw218","article-title":"TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction","volume":"113","author":"Rogers","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.placenta.2025.11.013_bib71","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nrc2561","article-title":"Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies","volume":"9","author":"Isenberg","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.placenta.2025.11.013_bib72","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.thromres.2011.09.032","article-title":"Circulating levels of thrombospondin-1 are decreased in HELLP syndrome","volume":"129","author":"Stenczer","year":"2012","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.placenta.2025.11.013_bib73","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1021\/acs.jproteome.1c00935","article-title":"Serum or plasma (and which plasma), that is the question","volume":"21","author":"Vignoli","year":"2022","journal-title":"J. Proteome Res."},{"issue":"9","key":"10.1016\/j.placenta.2025.11.013_bib74","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1369\/0022155419851103","article-title":"Thrombospondin 1 and its diverse roles as a regulator of extracellular matrix in fibrotic disease","volume":"67","author":"Murphy-Ullrich","year":"2019","journal-title":"J. Histochem. Cytochem."},{"issue":"5","key":"10.1016\/j.placenta.2025.11.013_bib75","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00018-007-7486-z","article-title":"Thrombospondins in cancer","volume":"65","author":"Kazerounian","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"22","key":"10.1016\/j.placenta.2025.11.013_bib76","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1182\/blood-2009-09-242065","article-title":"Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis","volume":"115","author":"Zaslavsky","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.placenta.2025.11.013_bib77","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.matbio.2014.01.012","article-title":"Current understanding of the thrombospondin-1 interactome","volume":"37","author":"Resovi","year":"2014","journal-title":"Matrix Biol."},{"issue":"41","key":"10.1016\/j.placenta.2025.11.013_bib78","doi-asserted-by":"crossref","first-page":"32167","DOI":"10.1074\/jbc.M003834200","article-title":"Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity","volume":"275","author":"Bein","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.placenta.2025.11.013_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120132","article-title":"Extracellular matrix components in preeclampsia","volume":"568","author":"Fama","year":"2025","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.placenta.2025.11.013_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020681","article-title":"Hypoxia inhibits subretinal inflammation resolution Thrombospondin-1 dependently","volume":"23","author":"Touhami","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.placenta.2025.11.013_bib81","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1471-4914(01)02102-5","article-title":"Thrombospondins and tumor angiogenesis","volume":"7","author":"de Fraipont","year":"2001","journal-title":"Trends Mol. Med."},{"issue":"9","key":"10.1016\/j.placenta.2025.11.013_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/life11090893","article-title":"Hypertensive patients exhibit enhanced Thrombospondin-1 levels at high-altitude","volume":"11","author":"Sharma","year":"2021","journal-title":"Life"},{"issue":"6","key":"10.1016\/j.placenta.2025.11.013_bib83","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0022-2143(98)90131-7","article-title":"Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells","volume":"132","author":"Phelan","year":"1998","journal-title":"J. Lab Clin. Med."},{"issue":"Pt 2","key":"10.1016\/j.placenta.2025.11.013_bib84","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1113\/jphysiol.2007.144394","article-title":"When the lung is stretched, could it be thrombospondin via TGFbeta1 peptide activation?","volume":"584","author":"Warburton","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.placenta.2025.11.013_bib85","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.matbio.2017.12.009","article-title":"Thrombospondin-1 regulation of latent TGF-beta activation: a therapeutic target for fibrotic disease","volume":"68\u201369","author":"Murphy-Ullrich","year":"2018","journal-title":"Matrix Biol."},{"issue":"5","key":"10.1016\/j.placenta.2025.11.013_bib86","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1002\/jcp.27344","article-title":"Pre-eclampsia onset and SPARC: a possible involvement in placenta development","volume":"234","author":"Tossetta","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.placenta.2025.11.013_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084062","article-title":"Thrombospondin-1 CD47 signalling: from mechanisms to medicine","volume":"22","author":"Kale","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib88","article-title":"Dysregulated thrombospondin 1 and miRNA-29a-3p in severe COVID-19","volume":"12","author":"Kim","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1182\/blood.V65.1.79.79","article-title":"Monocytes and macrophages synthesize and secrete thrombospondin","volume":"65","author":"Jaffe","year":"1985","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.placenta.2025.11.013_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43142-6","article-title":"Gene regulation for inflammation and inflammation resolution differs between umbilical arterial and venous endothelial cells","volume":"13","author":"Michaeli","year":"2023","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.placenta.2025.11.013_bib91","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024536","article-title":"PSG7 and 9 (Pregnancy-Specific beta-1 glycoproteins 7 and 9): novel biomarkers for preeclampsia","volume":"11","author":"Kandel","year":"2022","journal-title":"J. Am. Heart Assoc."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425007490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425007490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:58:00Z","timestamp":1773835080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400425007490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":91,"alternative-id":["S0143400425007490"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2025.11.013","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombospondin-1 (THBS1) is dysregulated in preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2025.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}